http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#head http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#assertion http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#provenance http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#publicationInfo http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#assertion http://bio2rdf.org/drugbank:DB00605 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00605_DB00945 http://bio2rdf.org/drugbank:DB00945 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00605_DB00945 http://bio2rdf.org/drugbank_resource:DB00605_DB00945 http://purl.org/dc/terms/identifier drugbank_resource:DB00605_DB00945 http://bio2rdf.org/drugbank_resource:DB00605_DB00945 http://purl.org/dc/terms/title DDI between Sulindac and Acetylsalicylic acid - Risk of additive toxicity (e.g. bleed risk). Acetylsalicylic acid may decrease the serum concentration of sulindac. Sulindac may counteract the cardioprotective effects of acetylsalicylic acid. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if the interacting agent is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00605_DB00945 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00605_DB00945 http://www.w3.org/2000/01/rdf-schema#label DDI between Sulindac and Acetylsalicylic acid - Risk of additive toxicity (e.g. bleed risk). Acetylsalicylic acid may decrease the serum concentration of sulindac. Sulindac may counteract the cardioprotective effects of acetylsalicylic acid. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if the interacting agent is initiated, discontinued or dose changed. [drugbank_resource:DB00605_DB00945] http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#provenance http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#publicationInfo http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#signature.MCwCFCd_wrZewuDD http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#signature.MCwCFCd_wrZewuDD http://purl.org/nanopub/x/hasSignature MCwCFCd/wrZewuDD/yJDkztp/BCottz8AhQxubxtU8rktju44KoJJZ1Z+W7mbA== http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#signature.MCwCFCd_wrZewuDD http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://purl.org/dc/terms/created 2018-03-30T11:13:12.407+02:00 http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk#signature.MCwCFCd_wrZewuDD http://bio2rdf.org/drugbank_resource:DB00605_DB00945_nanopub.RAXk4ZVuJice4emcVGwvpOclKJ4UVgsON-4CPH5pH9cxk http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234